Surprisingly, while the TGF‐β/SMAD signalling was analysed in eleven tumours (one tumour/mouse), only four of these tumours showed bioluminescence above background levels, all of them among tumours injected with CAF‐sEVs (Figure 8b). Here, TGFB1 is linked to neoplasm.